The European Commission has granted marketing authorization for Gedeon Richter Ltd.’s Tuyory, a medicinal product intended for the treatment of chronic inflammatory diseases. This decision elevates the company’s biotechnology division to a new level, expanding the range of therapies available in Europe. Under the decision, the medicine will be available not only in the European […] The post Richter Expands Rheumatology Portfolio with EU-Approved Medicine appeared first on Hungary Today.